Benzinga's Top Pre-Market NASDAQ Losers

Rigel Pharmaceuticals Inc RIGL dipped 5.77% to $8 in the pre-market session. RIGL reported that it intends to offer and sell shares of its common stock in an underwritten public offering. Complete Genomics Inc GNOM dropped 1.65% to $13.10 in the pre-market trading. GNOM priced its underwritten public offering of 5,500,000 shares of its common stock at $12.50 per share. CoStar Group Inc CSGP fell 1.27% to $60.75 in the pre-market session. CSGP priced an offering of 3,750,000 shares of its common stock at a price of $60.00 per share. Shire plc SHPGY moved down 1.14% to $90.39 in the pre-market session. SHPGY's subsidiary Shire LLC received Paragraph IV Notice Letters from Amneal Pharmaceuticals LLC and Watson Laboratories Inc. Read more from Benzinga's Markets.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPre-Market OutlookMarketsBiotechnologyDiversified Commercial & Professional ServicesHealth CareIndustrialsPharmaceuticalsTop Pre-Market NASDAQ Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!